Elisa Rizzo

510 total citations
7 papers, 343 citations indexed

About

Elisa Rizzo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Statistics and Probability. According to data from OpenAlex, Elisa Rizzo has authored 7 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Statistics and Probability. Recurrent topics in Elisa Rizzo's work include Statistical Methods in Clinical Trials (3 papers), Vascular Tumors and Angiosarcomas (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). Elisa Rizzo is often cited by papers focused on Statistical Methods in Clinical Trials (3 papers), Vascular Tumors and Angiosarcomas (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). Elisa Rizzo collaborates with scholars based in Italy, Belgium and United Kingdom. Elisa Rizzo's co-authors include Xavier Paolettí, Ian Judson, Alessandro Gronchi, Winette T.A. van der Graaf, Saskia Litière, Hans Gelderblom, Sandrine Marréaud, Axel Le Cesne, Myrella Vlenterie and Jean‐Charles Soria and has published in prestigious journals such as Statistics in Medicine, European Journal of Cancer and Annals of Surgical Oncology.

In The Last Decade

Elisa Rizzo

7 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elisa Rizzo Italy	6	190	132	97	76	54	7	343
Peter W. Gieser United States	9	178 0.9×	284 2.2×	82 0.8×	21 0.3×	51 0.9×	9	560
Junshan Qiu United States	9	124 0.7×	48 0.4×	134 1.4×	23 0.3×	16 0.3×	22	422
Ariel B. Bourla United States	10	149 0.8×	141 1.1×	34 0.4×	89 1.2×	19 0.4×	17	397
Navdeep Pal United States	11	189 1.0×	127 1.0×	55 0.6×	90 1.2×	10 0.2×	26	689
D. A. Berry United States	12	307 1.6×	51 0.4×	73 0.8×	261 3.4×	15 0.3×	27	695
John H. Moon United States	8	188 1.0×	60 0.5×	90 0.9×	40 0.5×	15 0.3×	12	574
Joseph Gibbons United States	10	193 1.0×	180 1.4×	30 0.3×	71 0.9×	5 0.1×	17	491
Xuyang Song United States	9	331 1.7×	155 1.2×	25 0.3×	62 0.8×	9 0.2×	26	506
Shengchun Kong United States	9	312 1.6×	227 1.7×	72 0.7×	47 0.6×	7 0.1×	15	522
Chin-Yu Lin United States	7	133 0.7×	327 2.5×	16 0.2×	25 0.3×	9 0.2×	8	494

Countries citing papers authored by Elisa Rizzo

Since Specialization

Citations

This map shows the geographic impact of Elisa Rizzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Rizzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Rizzo more than expected).

Fields of papers citing papers by Elisa Rizzo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Rizzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Rizzo. The network helps show where Elisa Rizzo may publish in the future.

Co-authorship network of co-authors of Elisa Rizzo

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Rizzo. A scholar is included among the top collaborators of Elisa Rizzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Rizzo. Elisa Rizzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Sleijfer, Stefan, Elisa Rizzo, Saskia Litière, et al.. (2018). Predictors for doxorubicin-induced hematological toxicity and its association with outcome in advanced soft tissue sarcoma patients; a retrospective analysis of the EORTC-soft tissue and bone sarcoma group database. Acta Oncologica. 57(8). 1117–1126. 9 indexed citations

Vlenterie, Myrella, Saskia Litière, Elisa Rizzo, et al.. (2016). Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity. European Journal of Cancer. 58. 62–72. 113 indexed citations

Paolettí, Xavier, A. Doussau, Monia Ezzalfani, Elisa Rizzo, & Rodolphe Thiébaut. (2015). Dose finding with longitudinal data: simpler models, richer outcomes. Statistics in Medicine. 34(22). 2983–2998. 10 indexed citations

Paolettí, Xavier, Christophe Le Tourneau, Jaap Verweij, et al.. (2014). Defining dose-limiting toxicity for phase 1 trials of molecularly targeted agents: Results of a DLT-TARGETT international survey. European Journal of Cancer. 50(12). 2050–2056. 60 indexed citations

Postel‐Vinay, Sophie, Laurence Collette, Xavier Paolettí, et al.. (2014). Towards new methods for the determination of dose limiting toxicities and the assessment of the recommended dose for further studies of molecularly targeted agents – Dose-Limiting Toxicity and Toxicity Assessment Recommendation Group for Early Trials of Targeted therapies, an European Organisation for Research and Treatment of Cancer-led study. European Journal of Cancer. 50(12). 2040–2049. 92 indexed citations

Rossi, Carlo Riccardo, Gian Luca De Salvo, Simone Mocellin, et al.. (2008). Factors Predictive of Nonsentinel Lymph Node Involvement and Clinical Outcome in Melanoma Patients With Metastatic Sentinel Lymph Node. Annals of Surgical Oncology. 15(5). 1552–1552. 4 indexed citations

Rossi, Carlo Riccardo, Gian Luca De Salvo, Simone Mocellin, et al.. (2007). Factors Predictive of Nonsentinel Lymph Node Involvement and Clinical Outcome in Melanoma Patients With Metastatic Sentinel Lymph Node. Annals of Surgical Oncology. 15(4). 1202–1210. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact